Page last updated: 2024-09-03
e 5110 and clofibrate
e 5110 has been researched along with clofibrate in 1 studies
Compound Research Comparison
| Studies (e 5110) | Trials (e 5110) | Recent Studies (post-2010) (e 5110) | Studies (clofibrate) | Trials (clofibrate) | Recent Studies (post-2010) (clofibrate) |
|---|---|---|---|---|---|
| 12 | 0 | 0 | 3,859 | 314 | 131 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Hirata, M; Nishibe, Y | 1 |
Other Studies
1 other study(ies) available for e 5110 and clofibrate
| Article | Year |
|---|---|
Induction of cytochrome P450 3A (CYP 3A) by E 5110, a non-steroidal anti-inflammatory agent (NSAID), and typical CYP 3A inducers in primary cultures of dog hepatocytes.
Topics: 7-Alkoxycoumarin O-Dealkylase; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbamazepine; Cells, Cultured; Clofibrate; Clotrimazole; Cytochrome P-450 CYP2E1; Cytochrome P-450 Enzyme System; Dogs; Drug Interactions; Enzyme Induction; Liver; Male; Mixed Function Oxygenases; Omeprazole; Phenobarbital; Phenytoin; Pyrrolidinones; Rifampin; Steroid Hydroxylases | 1995 |